Two years ago, ABC News ran a segment (What Would You Do?) that showed Americans going out of their way to help strangers who could not afford their medication. Actors visited local pharmacies pretending they could not afford to pay for their much-needed prescription drugs – something that happens frequently in the U.S. Some people offered to help pay for part or all of the drug orders, and one man even left the pharmacy to get money from an ATM. In addition to financial assistance, these individuals also offered words of solidarity against the outrageous costs. Karen Wenberg (real person) told the woman (actress) she was helping: “Don’t be embarrassed. You know what? Medication is so f***ing expensive. There is no reason to be embarrassed… Sometimes we just pass on the good that’s been given to us.”
As we write this, Congress is marking up a new law, Stop Online Piracy Act (SOPA), one supported by the Obama administration that could effectively block Americans from acquiring safe and affordable medication from online pharmacies outside the U.S. As the government seeks to rein in spending, why do they want to stop consumers from getting non-tax-payer funded, affordable medication? When people go without medication, they can become sick or get sicker, putting a great burden on the health care system. To see what the government is doing, read RxRight.org’s guest post on techdirt. (more…)
Tagged with: ABC, assistance, brand name drugs, Congress, drug affordability, drug benefits, generic drugs, healthcare, high cost, legislation, local pharmacies, Medicare, pharmaceutical industry, PharmacyChecker Verification Program, prescription abandonment, prescription drugs, RxRights.org, savings, SOPA, Stop Online Piracy Act, tax-payers, tech dirt, United States, What Would You Do?
New research shows that the Medicare drug plan “doughnut hole” seriously endangers not only the pocketbook, but also the health of our nation’s seniors and other Medicare enrollees. Two separate studies released this month show that patients who reach the coverage gap are more likely to stop taking their medication than they are to switch to a cheaper drug: the Public Library of Science published Changes in Drug Utilization During a Gap in Insurance Coverage: An Examination of the Medicare Part D Coverage Gap, and the Kaiser Family Foundation Program on Medicare Policy published Understanding the Effects of the Medicare Part D Coverage Gap in 2008 and 2009.
The putative reason for the coverage gap is that the threshold will teach consumers to be aware of drug costs. Jennifer Polinski, ScD, MPH, the author of PLoS study says, “there is an expectation that people will seek less expensive drug options when they enter the donut hole.” However, these studies reveal that this is clearly not the case. Research from 2006 and 2007 shows that beneficiaries were 40% less likely to switch a drug if they did not receive financial assistance, as opposed to those beneficiaries who did. Likewise, the Kaiser study reveals that about 3.4 million, or 12%, of Part D enrollees who reached the gap in 2008 and 2009 discontinued their medication. (more…)
Tagged with: brand name drugs, coverage gap, doughnut hole, generic drugs, Kaiser, Medicare, Part D, PLoS, prescription abandonment, prescription non-adherence, Public Library of Science, research
We don’t mean to sound like a broken record, but more reports keep coming out informing us, and hopefully our elected officials, too, that people are not taking their medication due to cost. Most recently it is the Mayo Clinic.
Based on a study of 209 patients prescribed heart medications, researchers found that among patients who did a poor job following prescriptions, financial concern was the main reason: 46 percent reported that they had stopped taking statins or not filled a prescription because of cost, and 23 percent acknowledged skipping doses to save money.
If there was ever ambiguity about whether high drug prices are a major threat to the public health, there is no longer. Data gathered by the U.S. Center for Disease Control, the National Consumer’s League, and Harvard School of Public Health, and, now, from the Mayo Clinic proves the point. We’ve dedicated time and effort in finding solutions to this health emergency. Our Consumer Guide can help Americans alleviate this burden and our advocacy initiative provides them with a platform to speak up to their elected officials.
Tagged with: Advocacy, Center for Disease Control, consumer guide, Harvard School of Public Health, Mayo Clinic, medication, National Consumer's League, prescription abandonment, skipping medicine, United States